<DOC>
	<DOCNO>NCT02686619</DOCNO>
	<brief_summary>This multicentre , prospective , randomize , open-label study compare safety efficacy mycophenolate mofetil delay introduction sirolimus discontinuation cyclosporine , mycophenolate mofetil long term continuation cyclosporine renal transplant recipient receive daclizumab ( Zenapax ) induction treatment follow 8 month treatment corticosteroid . The anticipated time study treatment 12 month . Participants complete initial 12-month study provide write informed consent eligible participate 60-month follow-up phase .</brief_summary>
	<brief_title>Study Comparing Efficacy Safety Mycophenolate Mofetil ( Cellcept ) With Delayed Introduction Sirolimus Discontinuation Cyclosporine , With Those Mycophenolate Mofetil Long Term Continuation Cyclosporine Renal Transplant Recipients</brief_title>
	<detailed_description />
	<mesh_term>Daclizumab</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Immunoglobulin G</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>Receipt first cadaveric kidney graft Antilymphocyte antibodies panel reactive antibody ( PRA ) less 30 percent ( % ) ( historical peak and/or current value ) Cold ischaemia time le equal 36 hour Kidney live donor ; donor great ( &gt; ) 65 year age ; second renal graft , ; multiple organ transplant Known hypersensitivity drug study component History cancer malignancy previous 5 year , successfully treat spinocellular basal cell cancer Participant presenting , inclusion , either symptom suggestive active gastroduodenal ulcer , gastroduodenal ulcer confirm fibroscopy biopsy , require treatment Participant severe refractory hyperlipidaemia Pregnant woman nurse mother Exclusion Criteria Followup Phase : Episode acute rejection great equal grade I ( Banff classification ) Estimated creatinine clearance ( CrCl ) week 12 le ( &lt; ) 40 milliliter per minute ( mL/min ) ( CockcroftGault formula ) Serum creatinine variation &gt; 30 % 15 day randomization Proteinuria &gt; 1 gram/24 hour , mean mycophenolate mofetil dose &lt; 1.5 gram/day week randomization</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>